Aquaporin A/S

AQP

DK0061555109

Water Utilities

Market Closed - Nasdaq Copenhagen Other stock markets 15:43:36 23/05/2024 BST			5-day change	1st Jan Change
15.8 ^DKK	+1.61%		+12.06%	-65.65%

04-05	Transcript : Aquaporin A/S, 2023 Earnings Call, Apr 05, 2024
04-05	Aquaporin A/S Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Aquaporin A/S Announces CEO Changes, effective January 1, 2022

November 24, 2021 at 01:45 pm

On 24 November, Aquaporin's board approved the appointment of Matt Boczkowski, CCO and Deputy CEO as CEO of Aquaporin A/S. Matt Boczkowski will replace Peter Holme Jensen, who has been the CEO since the inception in 2005. The above appointments will be effective as of 1st of January 2022.

Latest news about Aquaporin A/S

Transcript : Aquaporin A/S, 2023 Earnings Call, Apr 05, 2024	04-05
Aquaporin A/S Reports Earnings Results for the Full Year Ended December 31, 2023	04-05	CI
Aquaporin A/S Provides Earnings Guidance for the Year 2024	04-05	CI
London Stocks Retreat Ahead of Final UK GDP Data for Q4 2023	03-25	MT
AstraZeneca Says Ultomiris Gets US FDA Approval to Treat Neuromyelitis Optica Spectrum Disorder	03-25	MT
AstraZeneca Bags US FDA Clearance for Rare Autoimmune Disease Treatment Ultomiris	03-25	MT
AstraZeneca Receives US Approval for Neuromyelitis Optica Spectrum Disorder Treatment	03-25	MT
Aquaporin Announces Changes in Executive Management Team	02-02	CI
Aquaporin A/S Provides Earnings Guidance for the Financial Year 2024	01-29	CI
Aquaporin A/S(CPSE:AQP) added to OMX Nordic Small Cap Index	01-04	CI
Aquaporin A/S Maintains Earnings Guidance for the Full Year 2023	11-16	CI
AstraZeneca's Soliris Approved in China for Treatment of Neuromyelitis Optica Spectrum Disorder	18/10/23	MT
AstraZeneca drug Solaris approved in China as NMOSD treatment	18/10/23	AN
AstraZeneca's Rare Inflammatory Disease Drug for Adults Wins First-in-Class Nod in China	18/10/23	MT
AstraZeneca working with FDA on Ultomiris risk evaluation changes	06/09/23	AN
Transcript : Aquaporin A/S, H1 2023 Earnings Call, Aug 25, 2023	25/08/23
Aquaporin A/S Reaffirms Earnings Guidance for the Year 2023	25/08/23	CI
Aquaporin A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23	CI
AstraZeneca's Ultomiris wins another approval in Japan	26/05/23	AN
AstraZeneca Wins First-in-Class Nod for Rare Inflammatory Disease Drug Ultomiris in Japan	26/05/23	MT
Aquaporin A/S Provides Earnings Guidance of the Full Year 2023	24/05/23	CI
AstraZeneca's Rare Inflammatory Disease Drug Wins First-in-Class EU Approval	10/05/23	MT
AstraZeneca's ultomiris recommended for EU approval	03/04/23	AN
AstraZeneca's Ultomiris Recommended for Marketing Authorization in EU	03/04/23	DJ
Correction: AstraZeneca's Rare Inflammatory Disease Drug Wins EU Health Agency's Positive Recommendation	03/04/23	MT

Chart Aquaporin A/S

Duration

Period

More charts

Company Profile

Aquaporin A/S is a Denmark-based water tech company delivering technology built on natureâs own water filtration. Aquaporin revolutionizes water purification by merging biotechnological techniques and classical engineering. The Companyâs aim is to commercialize biomimetic water membranes for households and industrial use in a variety of markets and applications. Aquaporin deploys direct sales, sales through distributors and commercial partnerships. Aquaporin operates through three segments; Drinking Water, Industrial Water, and Food & Beverage. The Companyâs products include: Forward osmosis membranes, Drinking water membranes, ZERO - water purifier, ONE - water purifier, Brackish water RO membranes and Aquaporin Inside technology.

Sector

Water Utilities

More about the company

Income Statement Evolution

More financial data

Ratings for Aquaporin A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Water Supply & Irrigation Systems

	1st Jan change	Capi.
AQUAPORIN A/S	-65.65%	52.52M
GUANGDONG INVESTMENT LIMITED	-19.19%	3.89B
BEIJING ENTERPRISES WATER GROUP LIMITED	+44.83%	3.19B
COMPANHIA CATARINENSE DE ÁGUAS E SANEAMENTO - CASAN	-.--%	2.11B
SJW GROUP	-13.48%	1.88B
COMPANHIA DE SANEAMENTO DO PARANÁ - SANEPAR	-2.21%	1.66B
COMPANHIA DE SANEAMENTO DE MINAS GERAIS	+0.34%	1.52B
MANILA WATER COMPANY, INC.	+49.46%	1.4B
GUANGDONG SHUNKONG DEVELOPMENT CO.,LTD.	-4.55%	1.27B
CHINA WATER AFFAIRS GROUP LIMITED	+32.17%	1.23B

Water Supply & Irrigation Systems

Aquaporin A/S

Equities

AQP

DK0061555109

Water Utilities

Aquaporin A/S Announces CEO Changes, effective January 1, 2022

Latest news about Aquaporin A/S

Chart Aquaporin A/S

Company Profile

Income Statement Evolution

Ratings for Aquaporin A/S

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Water Supply & Irrigation Systems